Navigation Links
VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA

First new multifocal contact lens from ACUVUE(R) in 11 years combines unique Stereo Precision Technology(TM) optics and innovative senofilcon A material to help contact lens wearers stay in contacts longer

JACKSONVILLE, Fla., May 7 /PRNewswire/ -- VISTAKON(R), Division of Johnson & Johnson Vision Care, Inc., today announced plans to introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA. The lens, which is the first new multifocal contact lens from the makers of ACUVUE(R) in 11 years, is now available in some U.S. eye care professionals' offices and distribution will grow throughout 2009.

(Photo: )

ACUVUE(R) OASYS(TM) for PRESBYOPIA combines new STEREO PRECISION TECHNOLOGY(TM) optics with senofilcon A, the same silicone hydrogel material of ACUVUE(R) OASYS(TM), and HYDRACLEAR(R) PLUS, the improved formulation of the unique HYDRACLEAR(R) technology that combines high performance base materials with a moisture-rich wetting agent. STEREO PRECISION TECHNOLOGY(TM) offers wearers clear and comfortable vision correction at all distances with less dependence on illumination than older generation multifocal contact lenses.

Presbyopia is a vision condition in which the natural lens of the eye gradually loses flexibility, making it difficult to focus on close objects. Everyone will experience presbyopia to some extent and its onset can begin to occur as early as in the late thirties and early forties. Currently, an estimated 90 million people in the United States have presbyopia or will develop it by 2014.

"Emerging or early presbyopes may begin to notice challenges with a multitude of near-point tasks such as looking at a menu, deciphering text from a cell phone or other handheld electronic device, or reading the GPS or satellite radio devices in their cars," explains Susan Resnick, O.D. "Besides struggling with their vision, many of these contact lens wearers also cite problems with dryness and discomfort and consider abandoning contact lens wear despite a strong desire to continue wearing them. The synergy of a proven comfortable material and innovative technologies in ACUVUE(R) OASYS(TM) for PRESBYOPIA provides contact lens wearers experiencing the early symptoms of presbyopia a better option for continued contact lens use."

Product Features & Benefits


STEREO PRECISION TECHNOLOGY(TM) provides wearers with a smooth transition in power over the front surface of the lens to provide balanced near and distance vision with less dependence on illumination and minimal glares, haloes or ghosting.

Senofilcon A

Senofilcon A, a new generation silicone hydrogel material is a breakthrough for contact lens wearers whose eyes can feel tired and dry in challenging environments, such as long hours of computer use, frequent ground or air travel, or everyday exposure to heated or air conditioned surroundings. Research confirms that senofilcon A can alleviate some of the common problems of soft contact lens wear, such as discomfort due to feelings of dryness, and contribute to longer hours of comfortable wear. The material is 50% smoother than other currently available silicone hydrogel lenses.


HYRACLEAR(R) PLUS, the improved formulation of the unique HYDRACLEAR(R) technology, combines high performance base materials with a moisture-rich wetting agent to create a more wettable, ultra smooth contact lens especially for challenging environments that can make eyes feel tired and dry.

CLASS I UV Blocking

ACUVUE(R) OASYS(TM) for PRESBYOPIA blocks greater than 96 percent of UVA rays and 99 percent of UVB rays, meeting the highest UV-blocking standards for contact lenses.* ** Although UV-blocking contact lenses provide important added protection for patients, they should not be viewed as a stand-alone solution. Contact lenses should always be worn in conjunction with high-quality UV-blocking sunglasses and a wide-brimmed hat for maximum UV protection for the eyes.

For more information, along with a free*** trial-pair certificate for ACUVUE(R) OASYS(TM) for PRESBYOPIA, visit An eye care professional will determine if ACUVUE(R) OASYS(TM) for PRESBYOPIA is right for you.

Important Information for Contact Lens Wearers: ACUVUE(R) OASYS(TM) for PRESBYOPIA is indicated for daily wear vision correction and may also be worn for up to 6 consecutive nights/7 days of extended wear as recommended by your eye care professional. Contact lenses should not be worn for longer periods than recommended by an eye care professional. As with all contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may also experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. For more complete information patients should talk to their eye care professional, or call 1-800-843-2020 or visit

* Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

** WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-Blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-Blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

***Professional exam and fitting fees not included. Valid only while supplies last.

ACUVUE(R), ACUVUE(R) OASYS(TM), HYDRACLEAR(R), VISTAKON(R) and STEREO PRECISION TECHNOLOGY(TM) are trademarks of Johnson & Johnson Vision Care, Inc.

Dr. Susan Resnick is a paid consultant for VISTAKON(R)

SOURCE VISTAKON, Division of Johnson & Johnson Vision Care, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Senate Introduces Legislation to Increase Access to Physical Therapist Services
2. Bono Mack, Lowey Introduce Bill To Improve the Health of Youth
3. Body-Jet Liposuction First Introduced in the United States
4. Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss
5. Video: Jewelry Television(R) Introduces DermaGem(TM)
6. First-Ever Standardized Scales to Measure the Skins Aging Process Are Introduced at the American Society for Aesthetic Plastic Surgerys Annual Meeting
7. SignatureForum Introduces
8. U.S. Representatives Hill and Murphy Introduce the Men and Families Health Care Act of 2009
9. Microsoft Introduces Groundbreaking Technology for Life Sciences
10. Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
11. Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill
Post Your Comments:
(Date:11/30/2015)... ... 30, 2015 , ... California-based i2i Systems, a pioneer defining ... Michigan-based Family Health Center (FHC) has selected i2iTracks as their population health management ... the largest Affordable Care Act grant for Federally Qualified Health Centers in the ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... two new additions to its industry-leading suite of automated breast density assessment ... North America (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... 2015 , ... Scott Newman MD, FACS of New York’s ... surgeons in the New York City area to utilize the new, non-invasive SculpSure™ ... laser treatment for fat loss in the abdomen, flanks, and other areas that ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... healthcare professionals worldwide today released the results of a survey of educational needs ... and Africa found a growing global demand for high quality online and face-to-face ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... the norm in U.S. medical imaging is ... increasingly popular accountable care payer-provider contracts are ... and, in their wake, alter provider-vendor relationships. ... payments will push forward new purchasing frameworks ...
(Date:11/30/2015)... JERUSALEM , Nov. 30, 2015 Oramed ... company focused on the development of oral drug delivery ... investment agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of ... Oramed,s oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology: